This project measured the cost-effectiveness and short-term clinical outcomes of the use of genomics in health care through the four Round 1 Clinical Demonstration Projects.

The initial focus was on health economics but as the project progressed it measured a broader range of outcomes, such as the:

  • long term cost to society and impact of diseases
  • benefits to patients and their families who receive tailored care.
Project Deliverables

To ensure Queensland is equipped to apply medical genomics to everyday healthcare, a number of capability building projects were funded in Round 1.

Evaluation Framework
  • A framework for evaluating clinical genomics
Clinical Demonstration Project Outcomes:
  • An evaluation report detailing the four clinical demonstration project outcomes and results from applying the evaluation framework
Project Investigators

Project leaders engage with and draw upon the expertise of partners within universities, research institutes and hospital and health services around Queensland.

Associate Professor Louisa Gordon, QIMR Berghofer Medical Research Institute (Lead)

Professor Nicholas Graves, Queensland University of Technology

Professor Penelope Webb, QIMR Berghofer Medical Research Institute

Professor Sunil Lakhani, Pathology Queensland and UQ Centre for Clinical Research

Professor Lyn Griffiths, Queensland University of Technology

Associate Professor Amanda Spurdle, QIMR Berghofer Medical Research Institute

Dr Nic Waddell, QIMR Berghofer Medical Research Institute

Professor Deborah Schofield, The University of Sydney

Dr Rupendra Shrestha, The University of Sydney

Dr Michelle Cunich, The University of Sydney

Dr Khurshid Alam, Murdoch Children’s Research Institute

Owen Tan, The University of Sydney

Luke Rynehart, Murdoch Children’s Research Institute

Dr Sharyn Lymer, The University of Sydney

Sarah West, The University of Sydney

Round 1 – Capability-building projects

Your blood, your story
Community Engagement

Genomics resources for Aboriginal & Torres Strait Islander Peoples


Round 3 Investment

Infectious disease

Genome sequencing shown to curb disease outbreaks